{"symbol":"JNJ","fiscalQuarter":"Q3-2023","reportDate":"2023-10-17","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2023","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Down N/A%","keyNumbers":[{"metric":"EPS","actual":"$2.66","expected":"N/A","surprise":"+5.39%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted strong performance in key product areas.","They expressed confidence in long-term growth despite current market challenges."],"summary":"Overall, management conveyed a sense of cautious optimism regarding future performance. They emphasized the strength of their product pipeline."},"guidanceChanges":{"summary":"No forward guidance was provided in this earnings report.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson has exceeded expectations on EPS, which may reflect operational efficiency or strong product demand. However, the lack of revenue data and guidance could leave investors uncertain about future performance. The stock reaction is not available, but the positive EPS surprise suggests some investor confidence.","metaDescription":"Johnson & Johnson (JNJ) Q3 2023 earnings: EPS beat by 5.39%. Stock down N/A%. Full breakdown."}}